NOVOZYMES A/S/S (OTCMKTS:NVZMY) will be releasing its earnings data on Wednesday, October 23rd. Analysts expect NOVOZYMES A/S/S to post earnings of $0.43 per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.
NOVOZYMES A/S/S (OTCMKTS:NVZMY) last released its quarterly earnings results on Thursday, August 8th. The biotechnology company reported $0.47 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.53 by ($0.06). The business had revenue of $520.49 million for the quarter, compared to the consensus estimate of $556.19 million. NOVOZYMES A/S/S had a net margin of 22.31% and a return on equity of 28.54%. On average, analysts expect NOVOZYMES A/S/S to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
NVZMY stock opened at $43.07 on Tuesday. The company has a fifty day moving average price of $42.73 and a 200-day moving average price of $45.27. The company has a market capitalization of $12.74 billion, a P/E ratio of 25.09, a PEG ratio of 2.03 and a beta of 0.75. NOVOZYMES A/S/S has a 52-week low of $39.96 and a 52-week high of $52.50. The company has a debt-to-equity ratio of 0.05, a quick ratio of 0.75 and a current ratio of 1.27.
NOVOZYMES A/S/S Company Profile
Novozymes A/S produces and sells industrial enzymes and microorganisms worldwide. The company offers agriculture solutions, including crop protection, and animal health and nutrition solutions; fermentation, lignecellulosic hydrolysis, liquefaction, process enhancement, and saccharifaction solutions for bioenergy; baking, beverages, dairy, and protein ingredients for the food and beverage industry; and laundry, dishwashing, hand washing, and cleaning solutions for the household care industry.
Recommended Story: Why Invest in Dividend Achievers?
Receive News & Ratings for NOVOZYMES A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NOVOZYMES A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.